JHS Svendgaard Laboratories Intrinsic Value

JHS Svendgaard Laboratories intrinsic value. JHS Svendgaard Laboratories (JHS) median intrinsic value is ₹5.52 from 7 valuation models (range ₹4–₹20), vs current price ₹11.70 — -52.8% downside (Trading Above Calculated Value), margin of safety -100.0%. Analyse JHS FII DII holdings to track promoter, FII and institutional holdings.

Market Price (CMP)
₹11.70
Primary Intrinsic Value
₹3.51
Market Cap
₹101.8 Cr
-52.8% Downside
Median Value
₹5.52
Value Range
₹4 - ₹20
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

JHS Valuation Methods Summary — DCF, Graham Number & P/E

JHS Svendgaard Laboratories intrinsic value across 7 models vs current price ₹11.70 — upside/downside and value range per method. Browse JHS cash flow statement for revenue, profit, balance sheet and cash flow data.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹3.51 ₹2.81 - ₹4.21 -70.0% EPS: ₹0.24, Sector P/E: 12x
Book Value Method asset ₹20.11 ₹18.10 - ₹22.12 +71.9% Book Value/Share: ₹20.11, P/B: 1.0x
Revenue Multiple Method revenue ₹8.46 ₹7.61 - ₹9.31 -27.7% Revenue/Share: ₹10.57, P/S: 0.8x
EBITDA Multiple Method earnings ₹5.52 ₹4.97 - ₹6.07 -52.8% EBITDA: ₹8.00Cr, EV/EBITDA: 6x
PEG Ratio Method growth ₹3.51 ₹3.16 - ₹3.86 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹3.51 ₹3.16 - ₹3.86 -70.0% Revenue Growth: 6.0%, Adj P/E: 8.2x
Graham Defensive Method conservative ₹10.42 ₹9.38 - ₹11.46 -10.9% EPS: ₹0.24, BVPS: ₹20.11
Method Types: Earnings Asset DCF Growth Dividend Conservative

JHS Intrinsic Value vs Market Price — All Valuation Models

JHS Svendgaard Laboratories fair value range ₹4–₹20 vs current market price ₹11.70 across 7 valuation models. For current market price and key ratios, visit JHS share price screener.

JHS Intrinsic Value Analysis — Undervalued or Overvalued?

JHS Svendgaard Laboratories median intrinsic value ₹5.52, current price ₹11.70 — Trading Above Calculated Value by 52.8%, margin of safety -100.0%.

What is the intrinsic value of JHS?

Based on our comprehensive analysis using 7 different valuation methods, the estimated intrinsic value of JHS Svendgaard Laboratories (JHS) is ₹5.52 (median value). With the current market price of ₹11.70, this represents a -52.8% variance from our estimated fair value.

The valuation range spans from ₹3.51 to ₹20.11, indicating ₹3.51 - ₹20.11.

Is JHS undervalued or overvalued?

Based on our multi-method analysis, JHS Svendgaard Laboratories (JHS) appears to be trading above calculated value by approximately 52.8%.

JHS Financial Health — Key Ratios vs Industry Benchmarks

JHS Svendgaard Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Return on Equity 2.3% Industry Standard: 15%+ Below 10% Measures shareholder return efficiency
Operating Margin 2.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 0.43x Industry Standard: 1.0x+ Below 0.5x Measures asset utilization efficiency

JHS Cash Flow Quality — Operating & Free Cash Flow

JHS Svendgaard Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹-3 Cr ₹-9 Cr Negative Cash Flow 3/10
March 2025 ₹-5 Cr ₹-15 Cr Negative Cash Flow 3/10
March 2024 ₹-9 Cr ₹-20 Cr Negative Cash Flow 3/10
March 2023 ₹23 Cr ₹23 Cr Positive Free Cash Flow 8/10
March 2022 ₹-9 Cr ₹-12 Cr Negative Cash Flow 3/10